Chronic Kidney Disease Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Chronic Kidney Disease stocks.

Chronic Kidney Disease Stocks Recent News

Date Stock Title
Aug 1 SNY Regeneron (REGN) Tops on Q2 Earnings, Eylea HD, Dupixent Fuel Sales
Jul 31 SNY Sanofi unit Genzyme sues Sarepta alleging patent infringement in Duchenne drug
Jul 31 FGEN FibroGen axes 75% of staff after lead cancer therapy fails in Phase III trials
Jul 31 FGEN Vertex’s pain drug gets speedy FDA review; Keytruda hits a sales milestone
Jul 31 FGEN Why AMD Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
Jul 30 FGEN FibroGen stock plunges 48% post-market on failed drug studies
Jul 30 FGEN FibroGen to Report Second Quarter 2024 Financial Results
Jul 30 SNY Novavax Sinks 26%. Vaccine Demand Triggers Downgrade.
Jul 30 FGEN FibroGen Announces Topline Results from Two Late-Stage Pamrevlumab Pancreatic Cancer Studies and Provides Corporate Update
Jul 30 PROK ProKidney Corp.'s (NASDAQ:PROK) top owners are retail investors with 32% stake, while 30% is held by institutions
Jul 30 AZN AstraZeneca reports positive data from chronic lymphocytic leukaemia therapy trial
Jul 30 AZN NICE not to recommend Daiichi Sankyo-AstraZeneca’s Enhertu for NHS
Jul 29 AKBA Akebia Therapeutics to Present at Upcoming Investor Conferences
Jul 29 FGEN FibroGen, Inc. (NASDAQ:FGEN) is a favorite amongst institutional investors who own 54%
Jul 29 AZN Fixed-duration CALQUENCE® (acalabrutinib) plus venetoclax, with or without obinutuzumab, significantly improved progression-free survival in 1st-line chronic lymphocytic leukemia in AMPLIFY Phase III trial
Jul 28 AZN AstraZeneca (LON:AZN) Has Announced A Dividend Of $0.776
Jul 27 AZN AstraZeneca Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Jul 26 AZN FDA committee proposes overhaul of perioperative lung cancer trials
Jul 26 AZN 3 Surprisingly Underrated Stocks to Buy Right Now
Jul 26 SNY Fluzone® High-Dose Quadrivalent vaccine remains preferentially recommended to protect adults 65 years of age and older against influenza
Chronic Kidney Disease

Chronic kidney disease (CKD) is a type of kidney disease in which there is gradual loss of kidney function over a period of months or years. Early on there are typically no symptoms. Later, leg swelling, feeling tired, vomiting, loss of appetite, or confusion may develop. Complications may include heart disease, high blood pressure, bone disease, or anemia.Causes of chronic kidney disease include diabetes, high blood pressure, glomerulonephritis, and polycystic kidney disease. Risk factors include a family history of the condition. Diagnosis is generally by blood tests to measure the glomerular filtration rate and urine tests to measure albumin. Further tests such as an ultrasound or kidney biopsy may be done to determine the underlying cause. A number of different classification systems exist.Screening at-risk people is recommended. Initial treatments may include medications to manage blood pressure, blood sugar, and lower cholesterol. NSAIDs should be avoided. Other recommended measures include staying active and certain dietary changes. Severe disease may require hemodialysis, peritoneal dialysis, or a kidney transplant. Treatments for anemia and bone disease may also be required.Chronic kidney disease affected 753 million people globally in 2016, including 417 million females and 336 million males. In 2015 it resulted in 1.2 million deaths, up from 409,000 in 1990. The causes that contribute to the greatest number of deaths are high blood pressure at 550,000, followed by diabetes at 418,000, and glomerulonephritis at 238,000.

Browse All Tags